Biotech ETF Rises 17% in a Month Without NVIDIA
A biotech ETF posts a 17% gain in the trailing month even as NVIDIA weakens, underscoring a sector rotation that chal...
An overview of where to locate stock index listings worldwide, with guidance on finding the right benchmarks for your analysis.
17,106 articlesA biotech ETF posts a 17% gain in the trailing month even as NVIDIA weakens, underscoring a sector rotation that chal...
Abu Dhabi Securities Exchange and Dubai Financial Market will suspend trading for two days amid escalating regional t...
Unlock the power of a steady Tuesday reads habit. This guide helps you turn morning market news into smarter investin...
Wave Life Sciences slumped after INLIGHT readouts failed to establish WVE-007 as a solo obesity treatment, triggering...
With summer on the horizon, investors wonder if XLE should ride along in their portfolios. This guide weighs the case...
The AI IPO race is accelerating as OpenAI joins the fray after Anthropic. This article breaks down what the filing me...
SpaceX has surged into the spotlight on Hyperliquid, driving the spacex most popular trade narrative. This guide digs...
SpaceX’s public debut has revived a long-standing fight over dual-class voting. Investors and watchdogs are weighing ...
Markets retreat as geopolitical risk and currency headwinds weigh on miners and industrials. Linde and Southern Coppe...
NVIDIA just reported billion-dollar revenue, underscoring a surge in AI infrastructure spending. This article explain...
A geopolitical chokepoint isn't just about oil. The Strait of Hormuz also moves a vital portion of global fertilizer....
Retirees are turning to a simple, low-cost income strategy: a 50/50 blend of municipal bonds and dividend equities to...